Pan Am Farma

Nivolumab 40mg/4mL

Product Overview
Generic NameNivolumab 40mg/4mL
Brand Name(s)Opdivo
FormIntravenous solution vial; 10 mg/mL concentration
Strength40 mg/4 mL
Therapeutic ClassPD-1 immune checkpoint inhibitor
ATC CodeL01FF01
Manufacturing & Regulatory
ManufacturerBristol-Myers Squibb
CountryUSA, India
GMP ComplianceWHO-GMP
DMF/CEPNot publicly disclosed
COFEPRISPending
Free Sale CertificateYes
Logistics & Export
MOQ5 units
Shelf Life24 Months
StorageRefrigerated (2–8 °C)
IncotermsEXW/FOB/CIF negotiable
Lead Time7 - 10 Business Days
Documentation
Certificate of Analysis (COA)Supplied per batch upon request
SDSUpon Request, not publicly posted
CTD SummaryFull CTD dossier proprietary; available under commercial agreement/license

Description

Indications & Usage:Nivolumab (40 mg vial) is indicated as monotherapy or in combination for numerous advanced malignancies: unresectable/metastatic melanoma, NSCLC, malignant pleural mesothelioma, renal cell carcinoma, classical Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial carcinoma, MSI-H/dMMR colorectal cancer, hepatocellular carcinoma, esophageal/gastric/gastroesophageal junction cancers, among others

Request for Quote
Shopping cart0
There are no products in the cart!
Continue shopping
Productos